Clinical trial
Electrophysiological Effects of Irbesartan in Patients With Paroxysmal Atrial…
NCT00352560 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00352560 |
|---|---|
| Title | Electrophysiological Effects of Irbesartan in Patients With Paroxysmal Atrial Fibrillation (AF) |
| Official title | Electrophysiological Effects of Irbesartan in Patients With Paroxysmal Atrial Fibrillation (AF) |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Collaborators | Sanofi Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation |
| Intervention type | Drug |
| Interventions | Irbesartan, Placebo |
| Enrollment | 44 |
| Start date | Jul 1, 2006 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Jul 14, 2006 |
| Last update posted | Feb 17, 2010 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: